Channing Capital Management, LLC

Position in ABBV — AbbVie Inc.

CIK 1302404 Chicago, IL

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$16,250,407

+$2,861,288 QoQ

Shares Held

64,578

+4.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#704

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 30% Shared 0% None 70%

Healthcare · as of Jun 30, 2026

Channing Capital Management, LLC holds $25,323,008 across 2 Drug Manufacturers - General names. ABBV ranks #1 (64.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	ABBV	AbbVie Inc. This page	64,578	$16,250,407
2	GILD	Gilead Sciences, Inc.	71,811	$9,072,601

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,250,407	64,578	+4.9%	Shares	Sole	2026-07-29
2026-03-31	$13,389,119	61,562	+7.9%	Shares	Sole	2026-05-14
2025-12-31	$13,037,410	57,059	+2.5%	Shares	Sole	2026-02-13
2025-09-30	$12,884,506	55,647	+10.5%	Shares	Sole	2025-11-10
2025-06-30	$9,345,038	50,345	+4.7%	Shares	Sole	2025-08-13
2025-03-31	$10,072,674	48,075	-20.9%	Shares	Sole	2025-05-14
2024-12-31	$10,803,804	60,798	+9.7%	Shares	Sole	2025-02-07
2024-09-30	$10,940,589	55,401	-5.0%	Shares	Sole	2024-11-13
2024-06-30	$10,001,674	58,312	+11.1%	Shares	Sole	2024-08-14
2024-03-31	$9,557,700	52,486	-11.0%	Shares	Sole	2024-05-15
2023-12-31	$9,141,060	58,986	+5.6%	Shares	Sole	2024-02-06
2023-09-30	$8,322,616	55,834	-10.9%	Shares	Sole	2023-11-13
2023-06-30	$8,442,855	62,665	+17.2%	Shares	Sole	2023-08-11
2023-03-31	$8,517,848	53,447	-23.0%	Shares	Sole	2023-05-09
2022-12-31	$11,220,743	69,431	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.